Wellgistics Health (NASDAQ:WGRX - Get Free Report) issued its earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, Zacks reports.
Wellgistics Health Stock Performance
Shares of NASDAQ:WGRX traded up $0.1204 during midday trading on Tuesday, reaching $0.8704. The company's stock had a trading volume of 4,293,269 shares, compared to its average volume of 1,399,547. Wellgistics Health has a fifty-two week low of $0.6150 and a fifty-two week high of $7.04. The company has a debt-to-equity ratio of 1.43, a quick ratio of 0.15 and a current ratio of 0.36. The stock's fifty day simple moving average is $0.93.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen cut Wellgistics Health from a "hold" rating to a "sell" rating in a research report on Saturday, July 26th.
Read Our Latest Research Report on WGRX
About Wellgistics Health
(
Get Free Report)
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Wellgistics Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Wellgistics Health wasn't on the list.
While Wellgistics Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access